NCT04285814View on ClinicalTrials.gov

Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions
Copy Number AbnormalityPrenatal DiagnosisGenetic Disease
Interventions
DIAGNOSTIC_TEST

Whole Fetal Cell (WFC) Testing

Performing WFC testing on blood specimens.

Trial Locations (2)

10032

Columbia University, New York

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Columbia University

OTHER

NCT04285814 - Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood | Biotech Hunter | Biotech Hunter